Category: Business of health

10/18/2017

Sponsored content: Boston Globe + Pfizer = News? Really?

1 10/11/2017

More evidence that women should be wary of ‘ovarian reserve testing’ events

3 9/26/2017

A prostate ‘Pep Talk’ is the wrong way to get men thinking about cancer screening

6 9/5/2017

Facts about the new ALS drug Radicava that you’re unlikely to see in news stories

1 9/1/2017

A $475,000 cancer drug: Wall Street sees ‘bargain’; patients see ‘completely broken’ system

8/16/2017

Investors aren’t the only ones burned by misleading drug company news releases

8/14/2017

Why you should be wary of ‘ovarian reserve testing’ events at fertility clinics

1 7/20/2017

Journalists and consumers need to immunize themselves against hype about unproven vaccines

7/19/2017

Stem cell ads: Promise much, deliver little

4 5/16/2017

Cashing in on emotions: How pharma profits from medicalizing the normal spectrum of feelings